Northwest Adult Congenital Heart Disease Observatory

Northwest Inter Hospital Adult Congenital Heart Disease Observatory

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02897323

Acronym

CARL

Enrollment

4000

Registered

2016-09-13

Start date

2016-11-14

Completion date

2020-10-31

Last updated

2017-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Brief summary

The incidence of congenital heart disease is about 8 per thousand live births. Thanks to advances in cardiac surgery, 90% of children born with heart defects reach adolescence and adulthood. Congenital heart defects are the leading cause of heart disease in young adults and expectant mothers in Western countries. The number of patients increases continuously as life expectancy increases. An increasing number of patients with complex heart defects survive to adulthood. The medico-surgical management of this highly specialized growing number of patients is difficult and requires a multidisciplinary collaboration. In France, an estimated 200,000 patients the number of carrier patients with congenital heart disease. Half of them will require monitoring, medical procedures, catheterizations and/or surgical re-intervention. No objective demographic data are currently available on the French patients. So, the investigators decided to set up an epidemiological project to better understand this cohort of patients. The main objective of this project is to obtain accurate epidemiological data needed to adapt the supply of care.

Interventions

OTHERdescription

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient, male or female, aged 18 years * Congenital heart disease operated or non-operated * Followed by a cardiologist specializing in congenital heart disease in the inter northwest region of France

Exclusion criteria

* Patient refusal

Design outcomes

Primary

Measure	Time frame	Description
patients characteristics description	baseline	Obtain epidemiological data on adult congenital of the population followed in northwest region of France

Secondary

Measure	Time frame
heart disease complications description	baseline
complications during pregnancy description	baseline

Countries

France

Contacts

Primary ContactFabien Labombarda

0231064767

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026